StockDriftsStockDriftsSK Bioscience (302440) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for SK Bioscience is dated 2025-12-09; the most recent is 2026-03-24. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-03-24 | BUY | 주식매수선택권 | 김훈 Kim Hoon | Global Business Representative | 21.9K | ₩42,150 | +5.1% | ₩921M ($640K) |
| 2026-01-01 | BUY | 신규선임 | 신지영 Jiyoung Shin | implementation | 11.3K | ₩48,000 | +4.2% | ₩541M ($376K) |
| 2026-01-01 | BUY | 신규선임 | 배정진 Bae Jeong-jin | implementation | 1.0K | ₩48,000 | +4.2% | ₩49M ($34K) |
| 2025-12-23 | BUY | 주식매수선택권 | 안재용 Jaeyong Ahn | CEO | 21.9K | ₩50,700 | -1.4% | ₩1.1B ($769K) |
| 2025-12-09 | BUY | 주식매수선택권 | 김훈 Kim Hoon | Global Business Representative | 21.9K | ₩53,100 | -5.8% | ₩1.2B ($806K) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for SK Bioscience. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.